Ivermectin's Potency Unproven Against Covid-19, Says BPOM
Translator
Editor
23 June 2021 08:49 WIB
TEMPO.CO, Jakarta - The Food and Drugs Monitoring Agency (BPOM) chairperson Penny K. Lukito on Tuesday commented on the ivermectin which has been claimed as a treatment for Covid-19. She said there is no definite research available yet in Indonesia to back the medication’s potency against the coronavirus.
Citing Bisnis.com, she insists that the ivermectin treatment is not an effective therapy and that it is also currently deemed as a medication against parasite infestation.
“The permit for Ivermectin at the BPOM is still as an anthelmintic and there is yet a clinical study proving the medication derived from chemicals to cure Covid-19 patients,” said the BPOM chair in a virtual event on Tuesday, June 22.
She believes the side effect of a medication that has not been backed by scientific research will be extremely dangerous , which is why the Indonesian government will not hastily claim the medication’s potency against coronavirus.
Lukita asserts that the BPOM will permit the distribution of the drug once there Ivermectin is tested clinically, which it currently has not.
Read: Task Force: No Permit from BPOM to Distribute Ivermectin as Covid Therapy Drug
BISNIS